Literature DB >> 7466598

Epinephrine as the initial therapy in selected cases of ocular hypertension.

S M Podos, R Ritch.   

Abstract

The authors believe that the epinephrines should be employed as the initial therapy in both primary open angle glaucoma and, when treated, ocular hypertension. Unlike pilocarpine, epinephrine does not produce miosis and accommodative spasm. Because of longer experience with epinephrine than with costly timolol, its longterm effectiveness and side effects are better known. Although the side effects of epinephrine are usually not serious, they may be intolerable to the patient. However, allergic blepharoconjunctivitis may be ameliorated by concomitant hydroxymesterone therapy. The availability of dipivalyl epinephrine (DPE) may decidedly shift the balance of the treatment of ocular hypertension, when indicated, to an epinephrine compound.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7466598     DOI: 10.1016/0039-6257(80)90097-1

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  2 in total

1.  A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.

Authors:  K B Mills; N A Jacobs
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

2.  Effect of topical application of adrenaline on Schlemm canal, trabecular meshwork and intraocular pressure.

Authors:  Meng Ye; Zhiqi Chen; Mu Li; Wei Chen; Hong Zhang; Junming Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.